Company news

AstraZeneca PLC news in 2016

AstraZeneca PLC's news releases, calls and decks from 2016, newest first.

View company

Az completes sale of antibiotics business

December 23, 2016

FDA accepts durvalumab for BLA in bladder cancer

December 9, 2016

Tagrisso data shows superiority over chemotherapy

December 6, 2016

AZ completes agreement for Rhinocort Aqua rights

December 5, 2016

AZ head and neck cancer trials resume enrolment

November 22, 2016

AZ out-licensing deal with Allergan completed

November 17, 2016

Year-To-Date and Q3 2016 Results

November 10, 2016

Dealing by Person Closely Associated

November 1, 2016

AZ completes US Aralez agreement for Toprol-XL

October 31, 2016

AstraZeneca Head and Neck Cancer Trials

October 27, 2016

Positive results in AstraZeneca Lynparza trial

October 26, 2016

FDA accepts for review ZS-9 NDA for hyperkalaemia

October 18, 2016

Az divests rights to Rhinocort Aqua outside US

October 7, 2016

AZ agreement with Aralez for Toprol-XL in US

October 4, 2016

AstraZeneca reports top-line EUCLID results in PAD

October 4, 2016

MedImmune out-licenses medicine to Allergan

October 3, 2016

Change to AstraZeneca board of directors

September 28, 2016

Decks in 2016